MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$5,914,459
Free Cash flow
-$1,642,129
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Accounts payable
Accrued expenses and other curre...
Others
Negative Cash Flow Breakdown
Net loss
Issuance costs related to issuan...
Purchase of property and equipme...
Payment of finance lease
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net loss
-2,324,013
3,499,430
-1,597,632
-3,821,039
Depreciation expense
28,193
-19,004
10,624
36,143
Stock-based compensation expense
-
-
183
-251
Non-cash interest expense for notes payable
-
-
0
0
Amortization of right-of-use asset
22,204
-53,310
21,000
54,105
Write-off and impairment of property and equipment
0
-34,189
36,574
495
Deferred offering costs
-
-
101,170
0
Prepaid expenses and other current assets
-66,967
457,168
-171,727
-291,460
Other non-current assets
-4,571
29,457
-13,437
-13,093
Accounts payable
453,801
-10,007
52,345
-36,305
Accrued expenses and other current liabilities
248,921
11,972
33,119
223,387
Net cash used in operating activities
-1,499,356
3,009,505
-1,359,793
-3,238,912
Purchase of property and equipment
142,773
18,989
0
0
Proceeds from sale of property and equipment
0
3,675
-
-
Net cash used in investing activities
-142,773
-15,314
0
0
Repayment of notes payable
-
-
0
0
Proceeds from issuance of notes payable, net of discounts of 287,580
-
-
0
0
Proceeds from issuance of common stock and pre-funded warrants, gross
8,499,835
-3,721,692
0
3,846,692
Issuance costs related to issuance of common stock
477,592
-
0
464,670
Proceeds from exercise of prefunded warrants
85
147
0
-
Payment of finance lease
1,070
-1,943
1,015
1,979
Net cash provided by financing activities
7,556,588
-3,254,932
-1,015
3,380,043
Increase in cash and cash equivalents
5,914,459
-260,741
-1,360,808
141,131
Cash and cash equivalents, beginning of period
3,082,268
3,082,268
4,301,945
-
Cash and cash equivalents, end of period
9,598,916
3,684,457
3,082,268
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock and...
$8,499,835
(120.96%↑ Y/Y)
Proceeds from exercise of
prefunded warrants
$85
Net cash provided by
financing activities
$7,556,588
(123.56%↑ Y/Y)
Canceled cashflow
$943,332
Increase in cash and cash
equivalents
$5,914,459
(4090.76%↑ Y/Y)
Canceled cashflow
$1,642,129
Issuance costs related to
issuance of common stock
$477,592
(2.78%↑ Y/Y)
something is missing
-$464,670
Payment of finance lease
$1,070
(-45.93%↓ Y/Y)
Accounts payable
$453,801
(1349.97%↑ Y/Y)
Accrued expenses and
other current...
$248,921
(11.43%↑ Y/Y)
Prepaid expenses and
other current assets
-$66,967
(77.02%↑ Y/Y)
Depreciation expense
$28,193
(-22.00%↓ Y/Y)
Amortization of right-of-use
asset
$22,204
(-58.96%↓ Y/Y)
Other non-current
assets
-$4,571
(65.09%↑ Y/Y)
Net cash used in
operating activities
-$1,499,356
(53.71%↑ Y/Y)
Net cash used in
investing activities
-$142,773
Canceled cashflow
$824,657
Net loss
-$2,324,013
(39.18%↑ Y/Y)
Purchase of property and
equipment
$142,773
Buy us a coffee
Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc. (BJDX)